Top 50 Medical VC Funds & Investors in Middle East (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Pontifax
VC Fund
|
10 | United States, Israel, France | Series A, Series B, Series C | Biotechnology, Health Care, Pharmaceutical | $4M–$104M |
|
OurCrowd
VC Fund
|
10 | Israel, United States, New Zealand | Series B, Series A, Seed | Software, Artificial Intelligence, Health Care | $612k–$70M |
|
HIMAngel
VC Fund
|
5 | Egypt, Saudi Arabia, United States | Seed, Pre-Seed, Convertible Note | Food and Beverage, E-Commerce, Manufacturing | $100k–$350k |
|
Btomorrow Ventures
VC Fund
|
4 | United States, United Kingdom, India | Series A, Seed, Series B | Health Care, Wellness, Food and Beverage | |
|
Triventures
VC Fund
|
4 | United States, Israel, Ireland | Series A, Series B | Health Care, Medical Device, Medical | $3.7M–$28M |
|
HBL Hadasit Bio Holdings
VC Fund
|
4 | Israel | Series A, Series B | Biotechnology, Medical, Health Care | |
|
Diffusion Capital Partners
VC Fund
|
4 | Turkey, United States, United Kingdom | Seed, Series A | Software, Information Technology, Artificial Intelligence | $439k–$2.7M |
|
Ziegler Meditech Equity Partners
VC Fund
|
3 | United States, Israel | Series C, Series E, Series F | Health Care, Biotechnology, Mobile | |
|
Terra Venture Partners
VC Fund
|
3 | Israel, United States | Seed, Series A, Series B | Software, Machine Learning, Artificial Intelligence | $1M–$30M |
|
Alumni Ventures
VC Fund
|
3 | United States, United Kingdom, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $1.4M–$86M |
|
A15
VC Fund
|
3 | Egypt, United States, United Arab Emirates | Seed, Pre-Seed | E-Commerce, Software, FinTech | $50k–$8M |
|
Docor International Management
VC Fund
|
3 | Israel, United States | Series C, Series A | Health Care, Biotechnology, 3D Technology | $13M–$22M |
|
Phoenician VC
VC Fund
|
3 | Lebanon, United Arab Emirates, Egypt | Seed, Series A | Financial Services, FinTech, Software | $700k–$8.4M |
|
Trendlines Group
VC Fund
|
3 | Israel, Singapore, United Kingdom | Seed, Series A | Health Care, Biotechnology, Medical Device | $650k–$15M |
|
F6 Ventures
VC Fund
|
3 | Egypt, United Arab Emirates, Saudi Arabia | Seed, Pre-Seed | Software, E-Commerce, Information Technology | $14k–$1.5M |
|
aMoon Fund
VC Fund
|
3 | United States, Israel, France | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $5.7M–$93M |
|
Falak Startups
VC Fund
|
3 | Egypt, United Arab Emirates, Canada | Pre-Seed, Seed | E-Commerce, Health Care, Mobile Apps | $6k–$1.2M |
|
DAI
VC Fund
|
2 | United States, Egypt | Seed | Health Care, Medical, Software | |
|
fresh.fund
VC Fund
|
2 | Israel, United States, Norway | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Software | $120k–$21M |
|
Arkin Holdings
VC Fund
|
2 | Israel, United States, Switzerland | Series A, Series B | Biotechnology, Health Care, Therapeutics | |
|
Indaco Venture Partners
VC Fund
|
2 | Italy, United States, United Kingdom | Series A, Series B | Biotechnology, Health Care, Medical | |
|
Integra Holdings
VC Fund
|
2 | Israel | Seed, Series B, Series F | Biotechnology, Pharmaceutical, Life Science | |
|
Kosgeb
VC Fund
|
2 | Turkey | Grant, Pre-Seed, Seed | Software, Health Care, Information Technology | $1k–$400k |
|
DEFTA Partners
VC Fund
|
2 | United States, Israel, Japan | Series A, Series B | Biotechnology, Medical, Software | |
|
AAIC Investment
VC Fund
|
2 | Kenya, Egypt, Nigeria | Seed, Series A, Series B | Health Care, Medical, E-Commerce | |
|
Eclipse
VC Fund
|
2 | United States, Canada, Israel | Series A, Series B, Seed | Software, Robotics, Artificial Intelligence | $2M–$105M |
|
Hanaco Venture Capital
VC Fund
|
2 | Israel, United States, United Kingdom | Series A, Seed, Series B | Software, FinTech, SaaS | $3M–$56M |
|
Mithril Capital Management
VC Fund
|
2 | United States, United Kingdom, Israel | Series C, Series B, Series D | Software, Health Care, Information Technology | $10M–$300M |
|
Smith & Nephew
VC Fund
|
2 | Israel, United States, United Kingdom | Series B, Series C | Medical Device, Medical, Health Care | |
|
Firstime Venture Capital
VC Fund
|
2 | Israel, United States, United Kingdom | Series A, Seed, Series B | Software, Artificial Intelligence, Health Care | $500k–$21M |
|
Grove Ventures
VC Fund
|
2 | Israel, United States | Seed, Series A, Series B | Artificial Intelligence, Software, Machine Learning | $3.5M–$74M |
|
Group 11
VC Fund
|
2 | United States, Israel | Series A, Series B, Seed | FinTech, Software, Financial Services | $1.5M–$100M |
|
Champel Capital
VC Fund
|
2 | Israel, United States, Switzerland | Series B, Series A, Seed | Artificial Intelligence, Health Care, Software | |
|
Shalom Equity Fund
VC Fund
|
2 | Israel | Seed | Medical, Sensor, Health Care | |
|
360 Nautica
VC Fund
|
2 | Qatar | Seed, Pre-Seed | Medical, E-Commerce, Health Care | |
|
Yozma Group
VC Fund
|
2 | Israel, United States, Australia | Series B, Seed | Health Care, Medical, Software | $2.5M–$59M |
|
Elron Ventures
VC Fund
|
2 | Israel, United States, China | Seed, Series A | Information Technology, Software, Health Care | |
|
Mindset Ventures
VC Fund
|
2 | United States, Israel, Canada | Series A, Seed, Series B | Software, Artificial Intelligence, Information Technology | |
|
S2G Ventures
VC Fund
|
2 | United States, Canada, Israel | Series A, Series B | Food and Beverage, Agriculture, Biotechnology | |
|
Flerie Invest
VC Fund
|
2 | Sweden, Israel, Iceland | Series A, Series B | Biotechnology, Health Care, Medical | |
|
Technion Seed
VC Fund
|
2 | Israel, United States | Series A, Seed | Health Care, Medical, Medical Device | |
|
TechWald Holding S.p.A.
VC Fund
|
2 | Israel, United States | Series A, Series B, Series C | Health Care, Medical, Medical Device | $3.6M–$20M |
|
TÜBİTAK
VC Fund
|
2 | Turkey, United Kingdom, United States | Grant, Pre-Seed, Seed | Software, Artificial Intelligence, Health Care | $3k–$2.5M |
|
XTX Ventures
VC Fund
|
2 | United Kingdom, United States, Israel | Series A, Seed | Artificial Intelligence, Software, Machine Learning | |
|
NFX
VC Fund
|
2 | United States, Israel, United Kingdom | Seed, Series A, Pre-Seed | Software, Information Technology, Marketplace | |
|
Binder & Partners Ventures
VC Fund
|
2 | Israel, France, United States | Seed, Pre-Seed, Series A | Software, Information Technology, Health Care | |
|
ZORA Ventures
VC Fund
|
2 | Israel, United States, United Kingdom | Seed, Series A, Convertible Note | Health Care, Biotechnology, Internet | $1M–$7M |
|
Clal Biotechnology Industries
VC Fund
|
2 | Israel, United States | Series A, Series B | Health Care, Biotechnology, Medical | $4M–$55M |
|
Good Company
VC Fund
|
2 | Israel, United States | Pre-Seed, Seed, Series A | Social Impact, Software, Recruiting | $400k–$22M |
|
Robin Hood Ventures
VC Fund
|
2 | United States, Israel | Seed, Series A | Software, Health Care, Biotechnology | $100k–$11M |
| Access all 50 VC funds in Middle East Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 106
- Round size: Series A $4M–$95M; Series B $20M–$100M; Series C $12M–$104M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $14M in 2020
Portfolio highlights
- Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
- Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
- Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Invest in exclusive and pre-vetted startups, late-stage companies, and top tier funds - private market access made simple, transparent, and institutional-grade.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series B, Series A, Seed
- Geography: Israel, United States, New Zealand
Investor stats
- Total investments: 261
- Round size: Seed $612k–$8M; Series A $5.3M–$22M; Series B $8M–$70M
- Lead/follow: 18% lead, 82% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Corgi Insurance — Corgi Insurance Services, Inc. ("Corgi") is an American technology company that operates an artificial intelligence (AI)-powered insurance carrier based in San Francisco, California. Corgi Insurance develops and operates a fully integrated insurance stack using AI agents to automate traditional carrier operations, becoming the world’sfirst “AI insurance company.” The company owns multiple subsidiaries operating under a dog-themed naming convention.
- PhenOlives — PhenOlives transforms olive oil waste into nutritious, gluten-free olive flour that retains the health benefits of olive oil. The company employs a patented process to create a high-fiber ingredient suitable for various baking and cooking applications.
- BetterSeeds — The company focuses on non-GMO genome editing using CRISPR-Cas9 for creating a novel breed of seeds and crop traits that address the 21st-century agriculture challenges. BetterSeeds provides advanced seeds enabling better crops for mechanized harvesting, extreme e climate resistance, higher calory and nutrient values, and more.
HIMAngel is a venture capital and private equity firm that supports early-stage startups to grow. It fills the funds' gap as there is an increasing focus on growth-stage VC funds, but little attention and even less money made available for early-stage investments. HIMAngel was founded in 2017 and headquartered in Cairo, Al Qahirah.
Show more...Investment focus
- Industry: Food and Beverage, E-Commerce, Manufacturing
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: Egypt, Saudi Arabia, United States
Investor stats
- Total investments: 26
- Round size: Seed $100k–$350k
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- Rology — AI-assisted On-demand Teleradiology Platform
- GBarena — GBarena is an online esports platform that serves the ecosystem stakeholders by the combination of a strong network of different esports communities, and a highly analytical tool to provide authentic value for all stakeholders (Publishers, Gamers, Tournament Organizers, Sponsors, Teams, and Media Partners).
- FreshSource — FreshSource is revolutionizing the agriculture value chain through a tech-based B2B platform that is disrupting the distribution model of horticulture produce.
Btomorrow Ventures (BTV) is the corporate venturing unit of BAT. BAT is building A Better Tomorrow by reducing the health impact of its business by transforming into a truly consumer-centric multi-category CPG company. We are dedicated to partnering with ambitious and passionate entrepreneurs to realise their vision by providing a platform toenhance innovation and accelerate growth.
Show more...Investment focus
- Industry: Health Care, Wellness, Food and Beverage
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, India
Investor stats
- Total investments: 44
- Lead/follow: no public data
Portfolio highlights
- Tru — Obsessively formulated by fusing flavor with function, each of our tasty innovations perform when you need it most. From the time you wake up until the second your head hits the pillow, we elevate every moment one sip at a time.
- Awake Chocolate — AWAKE Chocolate combines delicious milk chocolate.
- PHILTER Labs — Philter Labs presents an innovative smoke filter for E-Cig, Vape Pen, & CBD Pen. Filters smoke from entering shared space while you still enjoy the experience.
Triventures is a global, early stage fund that invests in exceptional entrepreneurs. We partner with disruptive ventures with innovative breakthroughs in healthcare and beyond. Our vision is to create a better, healthier future through data driven solutions and cross industry convergence.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series A, Series B
- Geography: United States, Israel, Ireland
Investor stats
- Total investments: 60
- Round size: Series A $3.7M–$20M; Series B $6M–$28M
- Lead/follow: 30% lead, 70% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Grin — Grin is a comprehensive digital orthodontic platform providing teeth straightening for all types of patients with a real local orthodontist. The platform also connects patients with a real orthodontist from the convenience of their smart device. They deliver responsible care from orthodontic specialists in an easily accessible and cost-effectiveway, Grin provides patients quality care that results in an exceptional smile together with all of the modernized convenience that they expect.Grin technology, aligned with a network of local trusted orthodontists, ensures that every patient gets the right care. The platform Grin App and Grin Scope is a patent-pending technology that offers remote monitoring for a variety of orthodontic needs. The Grin experience includes high-quality self-scans with the latest teeth straightening solutions. Practitioners and patients can now use these telemedicine tools to achieve a new, more convenient treatment journey.It was founded by Dr. Adam Schulhof, Pamela Oren-Artzi, and Alon Lipnik in 2019 and is based in New York and Austin.
- Cala Health — Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health's wearable therapy is an essential tremor, adisease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.
- TailorMed — Moving Mountains for Patients
Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Series B
- Geography: Israel
Investor stats
- Total investments: 9
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
- Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
Diffusion Capital Partners (DCP) is Turkey's leading Venture Capital fund manager with a focus on deep-tech opportunities.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A
- Geography: Turkey, United States, United Kingdom
Investor stats
- Total investments: 49
- Round size: Seed $439k–$2.7M; Series A $985k–$2.5M
- Lead/follow: 63% lead, 37% follow
- Last fund: May invest from a new fund soon — raised $32M in 2020
Portfolio highlights
- Boby.ai — Boby.ai develops artificial intelligence-supported mobile applications for end users
- V-Count — V-Count works with 550+ brands, 25.000+ locations in 105+ countries.
- PowerDev — PowerDev allows renewable energy contenders to make decisive and sustainable battery storage and green hydrogen investments.
Ziegler is a privately held investment bank, capital markets and proprietary investments firm.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Mobile
- Stage:Series C, Series E, Series F
- Geography: United States, Israel
Investor stats
- Total investments: 6
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Aposense — Aposense (formerly NST) is a clinical-stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo. The company translating the science of Apoptosis (programmed cell death) into personalized patient care in multiple diseasecategories, including oncology, cardiology, and neurology. Targeting of this important biological process in-vivo opens opportunities for real-time clinical imaging of disease activity and targeted therapy.Aposense specializing in the development of novel drugs and utilizing membrane electrical forces for trans-membrane of macromolecule drugs, mainly siRNA. It also developed rationally-designed molecular nano-motors (MNMs), being novel small-molecule chemical entities and its translation into kinetic energy for movement within the hydrophobic membrane core.Aposense was founded in 1996 and is headquartered in Petah Tiqva, HaMerkaz, Israel.
- MAKO Surgical — MAKO Surgical is a medical device company, markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures in the United States and internationally. The company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specificosteoarthritic disease. It also provides robotic arm interactive orthopedic system (RIO) consisting of a tactile robotic arm utilizing an integrated bone cutting instrument; and a patient specific visualization component, which offers pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal, and accurate implant insertion and alignment.In 2011, The company was named the No.1 on the Technology Fast 500 as the fastest growing technology company by Deloitte and received the CSSEC Award for loyal, customer-focused staff members presented by the Technology Services Industry Association and ACE Award (Achievement in Customer Excellence) from MarketTools and Fast Tech Award as one of the 25 fastest growing technology companies in South Florida by South Florida Business Journal.MAKO Surgical was founded in 2004 and is headquartered in Florida, USA.
- MobileAccess Networks — Corning Everon Network Solutions offer in-building cellular solutions to meet a broad array of design scenarios and mitigate RF propagation challenges.
We are an early stage venture capital firm dedicated to partnering with inspiring entrepreneurs to build breakthrough companies
Show more...Investment focus
- Industry: Software, Machine Learning, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 41
- Round size: Seed $1M–$2.5M; Series A $2.1M–$14M; Series B $15M–$30M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $31M in 2013
Portfolio highlights
- ViewNetic — ViewNetic is an AgTech startup developing unique imaging and machine learning technologies for early, pre-propagation detection of pests and diseases in high-value crops.
- Infiniplex — Infiniplex is an Israel-based startup whose mission is to utilize routine blood testing to screen for genetic tumor biomarkers and to offer preemptive, preventive, and follow-up cancer screenings at a more accessible and affordable cost. Our goal is to identify common and rare cancer types through a standard, inexpensive blood test that could becarried out as part of routine checkups, leveraging existing laboratory equipment and know-how. We aim to include tumor genomic testing as part of people's standard blood test checkups. The company was founded in 2021 and is based in Yokne'am Illit, Israel.
- Intuition Robotics — The AI care companion robot for older adults
Access curated startup investment opportunities and diversified venture capital exposure designed for accredited investors.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 1378
- Round size: Seed $1.4M–$10M; Series A $5M–$37M; Series B $12M–$86M
- Lead/follow: 15% lead, 85% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Humio — Humio operates as a time-series logging and aggregation platform designed for unrestricted and comprehensive event analysis. It is deployable on any infrastructure including both in the cloud and on-premises. Humio enables data aggregation, exploration, reporting, and analysis from a range of sources ingesting massive volumes of log data instantly.Its data storage and in-memory search/query engine technologies provide customers cost-competitive log management and analysis solution, all while requiring significantly less hardware and engineering resources.The company was founded in 2016 and is headquartered in London, England.
- OpusClip — Opus Clip turns long videos into high-quality viral clips for you to share on TikTok, YouTube Shorts, and Reels to increase social media reach.
- Arda Therapeutics — Arda Therapeutics is a biotechnology company taking aim at chronic diseases and aging by eliminating the pathogenic cells that drive these conditions. Their approach starts by using single-cell data to identify pathogenic cells and specific markers to target them. They then design therapies to eliminate these - and only these - cells.Arda wasfounded in 2021 in the San Francisco Bay Area, CA.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!A15 is an entrepreneurial company that invests in digital products and technology brands. They aspire to empower the human race to overcome its limits and expand its capabilities by creating real products for real people. They help them scale by providing them with investment, the support of our ecosystem, and act as their launchpad for expansion.It was founded in 1996 and is headquartered in Cairo, Egypt.
Show more...Investment focus
- Industry: E-Commerce, Software, FinTech
- Stage:Seed, Pre-Seed
- Geography: Egypt, United States, United Arab Emirates
Investor stats
- Total investments: 55
- Round size: Seed $100k–$8M; Pre-Seed $50k–$1.7M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- iVoiceUp —
- OneOrder — Oneorder delivers farm-fresh onions, potatoes, and peppers globally with cold-chain precision and trusted certifications.
- KNOT Technologies —
Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, 3D Technology
- Stage:Series C, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 14
- Round size: Series C $13M–$22M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Check-Cap — Check-Cap Ltd. is merging with MBody AI to create a leading publicly traded embodied AI company powering autonomous workforces.
- Ocon Healthcare — OCON Healthcare innovates, develops, manufactures, and commercializes cutting-edge women’s health products based on our patented IUB™ (Intra Uterine Ball) proprietary platform. The IUB™, made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.In addition to our flagshipproduct, the IUB™ Ballerine®, OCON healthcare is developing an innovative pipeline of products utilizing the IUB™ frame for indications such as abnormal uterine bleeding (AUB), heavy menstrual bleeding (HMS), myomas/fibroids, and infertility.
- Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
Founded in 2015, Phoenician Funds is at the heart of thriving capitals of digital innovation and startup ecosystems in the Middle East and North Africa ...
Show more...Investment focus
- Industry: Financial Services, FinTech, Software
- Stage:Seed, Series A
- Geography: Lebanon, United Arab Emirates, Egypt
Investor stats
- Total investments: 24
- Round size: Seed $700k–$3M; Series A $1.5M–$8.4M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $30M in 2015
Portfolio highlights
- Go Rise — Go Rise is a start-up building a financial services platform for migrants.
- Ostaz — Ostaz is a mobile and peer-to-peer educational platform connecting students seeking help in a specific course to qualified private tutors.
- TWIG — TWIG is a Bank Agnostic Automated Savings Platform in the MENA region. Our flagship app provides Automated Saving Plans to help users save better; a Smart Budgeting tool with tailored insights; and Smart, customizable and user-specific Goals.
Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Series A
- Geography: Israel, Singapore, United Kingdom
Investor stats
- Total investments: 67
- Round size: Seed $650k–$3.2M; Series A $2.3M–$15M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — raised $40M in 2019
Portfolio highlights
- IBI-Ag — IBI-Ag is a biotechnology company developing a new class of bioinsecticides. IBI-Ag is focused on the discovery and development of new types of biological solutions that utilize environmentally friendly technology to control insects. IBI-Ag utilizes breakthrough technology to produce efficient, selective, and safe bio-insect control solutions.IBI-Ag technology is highly cost-effective due to its fermentation suitability enabling farmers to produce agricultural produce at a low cost.
- Celleste Bio — Celleste is a business that specializes in employing cell culture techniques to produce high-value cocoa ingredients, removing the need for cocoa trees to be grown.
- Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.
F6 Ventures is a leading seed stage venture capital firm operating across emerging markets. We back exceptional founders from idea-stage all the way to Series A, combining early capital with strategic support and a commitment to long-term partnership. With deep ties across the Middle East, Africa, and beyond, we empower innovative startups to scalewith purpose and impact. We manage over $90M in AUM across more than 300 investments in seven countries. By investing early in Pre-Seed to Pre-Series A rounds, we help founders cover initial costs, develop their product, and take it to market. This early capital acts as a launchpad, enabling startups to hit key milestones like securing first customers, attracting follow-on funding, and making significant strides forward.
Show more...Investment focus
- Industry: Software, E-Commerce, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Egypt, United Arab Emirates, Saudi Arabia
Investor stats
- Total investments: 187
- Round size: Seed $14k–$1.5M; Pre-Seed $32k–$600k
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Emonovo — Best Study Abroad Partner in MENA to Find programs and universities around the world Emo was the 1st international student, now it is your turn to study abroad. Emonovo used to be named Marj3 which was highest reach scholarship portal in the MENA region.
- Brimore — Brimore is a social commerce platform connecting emerging brand owners with a network of resellers who market and sell their products using social media.
- Let'sGrant — Let’sGrant is a point of sale lending platform, partnering with lenders and consumer goods stores to make the lending process fast, simple and flexible for everyone. With a vision to be internationally recognized as a driving force in personal and consumer loans in the MENA region, Let’sGrant will soon be launching the first online peer to peerlending platform for personal loans in the MENA region which connects individual investors directly to potential borrowers in search of funding through debt.
aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science toaccelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 75
- Round size: Series A $5.7M–$83M; Series B $22M–$93M; Series C $30M–$82M
- Lead/follow: 51% lead, 49% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Adcytherix — Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
- Lin Health — Online chronic pain recovery program designed to get you back to the life you want to live. One-on-one coaching. Real pain reduction results.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
Falak Startups is a start-up accelerator designed to support and empower the next generation of Egyptian entrepreneurs and contribute to the development of the start-up ecosystem in Egypt.
Show more...Investment focus
- Industry: E-Commerce, Health Care, Mobile Apps
- Stage:Pre-Seed, Seed
- Geography: Egypt, United Arab Emirates, Canada
Investor stats
- Total investments: 70
- Round size: Seed $31k–$1.2M; Pre-Seed $6k–$250k
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- InCurA — Why InCurA ProductsWe Innovate Medical Devices for Today, Tomorrow and What's Needed NextInCurA is developing a pipeline of products based on its unique
- Tafatifi — Tafatifi is an online music platform that provides information regarding music events in Egypt. It is also a music based social media.
- Fincart — Fincart is a leading shipping platform in Egypt, connecting your business with top courier services, automating operations, and helping you scale your eCommerce logistics.
DAI works on the frontlines of global development transforming ideas into action—action into impact.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed
- Geography: United States, Egypt
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Rology — AI-assisted On-demand Teleradiology Platform
- THINKMD — THINKMD develops next-generation clinical assessment and data analytics platforms that transform point-of-care medicine by putting medically validated clinical assessment capability into the hands of non-healthcare professionals. This technology allows for the decentralization of healthcare delivery into communities and homes by pairing clinicalknowledge and Bayesian/pattern recognition algorithms with simple to use mobile technology. Its goal is to reinvent the healthcare delivery paradigm, reduce costs, and improve outcomes by improving healthcare access and care-seeking behavior while building a public health knowledge database.
- ClickMedix — Note: you must have a demo account to use the apps Improved Health Professionals Saved
fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio. It's never too early to have a conversation about your startup.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, Norway
Investor stats
- Total investments: 41
- Round size: Seed $3M–$12M; Pre-Seed $120k–$6M; Series A $11M–$21M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Wisio — Wisio lets social media creators and experts answer questions and requests from followers via paid interactions. The company’s platform empowers followers to gain exclusive access via personalized videos to their favorite creators. Wisio's flexible and easy-to-use platform is packed with features to help creators build deeper communitieswhile monetizing the creator - follower relationship. Thousands of them are already using it to help build their online reputation and business.Wisio's vision is to make everyone reachable.
- Clearitty — Clearitty - The Ultimate Sales Accelerator by Turning Deal Insights into Revenue We provide the tools and insights for sales executives to close deals faster and outperform competitors, empowering you to drive growth and success. It’s free to start — no trial, no contract, no risk.Clearitty was born out of a shared frustration experienced bysales executives and entrepreneurs alike – the lack of critical insights about new buyers. These invaluable insights are often held by those who have successfully navigated the sales process with these coveted clients.Recognizing the gap, in 2022 we created Clearitty, dedicated to developing an intelligence tool that helps sales executives shorten sales cycles and close deals more efficiently.Our goal is to build the world’s largest database of buyer insights, empowering sales executives with the knowledge they need to succeed.
- Sherloq — Ask your SQL anything. Built on your context, directly on your editor.
Explore Arkin Capital: A leading multi-asset manager driving strategic investments across health, technology, equity, real estate and more
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B
- Geography: Israel, United States, Switzerland
Investor stats
- Total investments: 27
- Lead/follow: no public data
Portfolio highlights
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- QuamCore — QuamCore is driving breakthroughs across industries by advancing the field of quantum computing, pushing the boundaries of what is possible, and bringing large-scale, commercially viable quantum computing to reality.
- Honeycomb — Honeycomb (fka Agilius) is the only place where you can buy a condo/apartment building master policy online in less than 3 minutes at a fraction of the cost! Instant, free, no hassle quotes, online everything and up to 40% savings. With all that we're bringing simplicity and transparency to the real estate insurance space for condoassociations (HOAs), building owners, property managers, and developers everywhere. This is what we do. This is all we do.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 28
- Lead/follow: no public data
Portfolio highlights
- Easy Rain — We are Easyrain. Continuous innovation runs in our blood.With our expertise, we develop, simulate, and test solutions, launching our ideas into production. We exploit the basic laws of physics to engineer a tangible solution!
- Sibylla Biotech — Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.
- Alia Therapeutics — Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.
Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies. Our golden eggs Ayana Pharma A late stage company with
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Life Science
- Stage:Seed, Series B, Series F
- Geography: Israel
Investor stats
- Total investments: 8
- Lead/follow: no public data
Portfolio highlights
- BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
- Splisense — Transformative RNA Based Treatments -Antisense Oligonucleotides- Targeting the Root Cause of Pulmonary Diseases Our innovative RNA based therapies, based on Antisense Oligonucleotides (ASOs), restore and modify protein functionality, addressing untreatable pulmonary diseases.
- Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria
Kosgeb is a government body dedicated to helping SMEs in their development through a variety of activities and services. They provide up to 6 million liras in support of SMEs in Turkey that would manufacture imported goods utilizing domestic and national resources.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Grant, Pre-Seed, Seed
- Geography: Turkey
Investor stats
- Total investments: 14
- Round size: Seed $6k–$165k; Grant $1k–$400k; Pre-Seed $4.4k–$150k
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Mistikist — Mistikist uses binaural beats for sleep and focus. This helps you relax, lower stress, and increase productivity in just minutes.
- a2 Technology — a2 Technology provides advanced solutions such as Automatic Plate Recognition Systems, Enforcement Systems, and Video Content Analysis with the scenario-based innovative video analysis algorithms based on the methodologies of artificial intelligence and machine learning. Thanks to its flexible and modular software architecture, a2 Technologyproducts are integrated with numerous camera brands and third-party systems such as video management software, automation applications, and public services.a2 Technology is able to serve in more than 80 countries on 5 continents with its global solution partners and local services. Proven solutions work 24/7 with high-performance in real-time at hundreds of points in various application areas in 22 countries.
- Vexnor Technology — Biomimetic Actuators, Wearable Robotics, Exoskeleton Technology, Artificial Muscles, Human-Machine Integration, Assistive Robotics, Industrial Ergonomics, Electromechanical Systems, HealthTech, DeepTech, Biomechanics, Robotics R&D, MedTech
DEFTA Partners is a venture capital firm focusing on technology. They primarily make seed and first round investments in early stage information technology companies with global opportunities to accelerate growth. DEFTA has offices and partners in the United States, Japan, Israel and the United Kingdom. via: DEFTA Partners
Show more...Investment focus
- Industry: Biotechnology, Medical, Software
- Stage:Series A, Series B
- Geography: United States, Israel, Japan
Investor stats
- Total investments: 31
- Lead/follow: no public data
Portfolio highlights
- InformAI — InformAI builds business analytics and artificial intelligence-based solutions for industry-leading healthcare organizations, medical device companies and imaging/PACS companies to improve mission outcome and operational improvement. The company provides computer consulting, artificial intelligence-based software solutions for imageclassification, natural language processing for operational processes, and prediction algorithms for mission-critical applications.InformAI develops AI-enabled healthcare diagnostic-assist tools and patient outcome predictors for leading healthcare systems and national physician groups. The company's AI software enables faster patient diagnoses at the point of care and improved patient outcome risk analysis.
- DiA Imaging Analysis — DiA is the leading provider of FDA cleared and CE marked ultrasound AI solutions that make the use and analysis of ultrasound images smarter, faster and accessible to all. Our solutions address the main challenges ultrasound users face - manually capturing and visually analyzing ultrasound images.
- Endogena — Endogena is a biotech company that develops endogenous regenerative medicines to repair and regenerate tissues and organs. Endogena's approach has the potential of a paradigm shift to treat degenerative conditions related to ageing and genetic disorders.The company implements innovation in the field of regenerative medicine. Their sciencecombines the latest developments in stem cell biology, AI, and expertise in small-molecule drug design to develop breakthrough treatments for degenerative diseases.
We will continue to invest and support the growth of innovative companies towards sustainable economic growth and solving social issues.
Show more...Investment focus
- Industry: Health Care, Medical, E-Commerce
- Stage:Seed, Series A, Series B
- Geography: Kenya, Egypt, Nigeria
Investor stats
- Total investments: 23
- Lead/follow: no public data
Portfolio highlights
- Mydawa — MYDAWA is here to ensure that every Kenyan can get quality, secure and affordable medicine and wellness products online
- Ilara Health — Ilara Health helps primary care clinics across Africa deliver better care.
- Lapaire — Get the best affordable eyeglasses in Africa with Lapaire. Book your free vision test today at our locations across Benin, Ivory Coast, Togo, Burkina Faso, Mali, Kenya & Uganda. Quality glasses, professional optometrists, unbeatable prices.
Palo Alto based Eclipse Ventures partners with entrepreneurs boldly transforming the essential industries that define and propel economies. Learn more.
Show more...Investment focus
- Industry: Software, Robotics, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 194
- Round size: Seed $2M–$24M; Series A $7.5M–$55M; Series B $15M–$105M
- Lead/follow: 52% lead, 48% follow
- Last fund: Likely still investing — raised $510M in 2023
Portfolio highlights
- Chord — Chord is a commerce data platform purpose-built for modern brands. Chord enables brands to unify, synthesize, and orchestrate their data to drive radical decisions and revenue.
- Jitsu — An expedited urban last-mile delivery service leveraging purpose-built technology and a gig driver fleet to catalyze client brand growth.
- Nucleus RadioPharma — Founded by Eclipse Ventures and Mayo Clinic, Nucleus RadioPharma is a new company built to ensure cancer patients can access potentially life-saving radiopharmaceuticals by developing technologies to modernize the clinical development, manufacturing, and supply chain of these promising new treatment tools.
Hanaco Venture Capital is a technology company with visionary and passionate entrepreneurs. Hanaco was founded by Alon Lifshitz, Lior Prosor, and Pasha Romanovski in 2017 and is headquartered in Tel Aviv, Israel.
Show more...Investment focus
- Industry: Software, FinTech, SaaS
- Stage:Series A, Seed, Series B
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 92
- Round size: Seed $3M–$11M; Series A $6M–$33M; Series B $20M–$56M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- Curve — Curve is a banking platform that consolidates cards and accounts into one smart card and app.It allows customers to supercharge their legacy banks to the 21st century without leaving their bank or topping-up. Curve offers a host of benefits to its customers; it makes cards fee-free when spending abroad, get instant notifications andcategorization of spend, earn an instant 1% cashback at the likes of Amazon, Uber, Netflix and Sainsbury’s and Time Travel enables customers to swap spend to a different card in the app for up to two weeks after the purchase was made. Curve also offers Curve Customer Protection, a policy that covers all credit and debit card payments made via the Curve card up to £100,000, giving cardholders an extra layer of protection for disputes with merchants and any unauthorised use of their Curve card. IDC Ventures backs Curve with Fuel Venture Capital, Vulcan Capital, OneMain Financial, and Novum Capital backs Curve.Shachar Bialick, Anna Mostyn Williams, and Tom Foster-Carter established the company in London, England in 2015.
- MDI Health — Transform Quality Metrics Clinical Outcomes & Costs all inOne Platform. Your AI Co-Pilot for Medication Management
- Route — Own the post-purchase experience with Route. Scale your brand using the #1 platform for package protection, AI-driven returns, and real-time tracking.
Mithril is a family of long-term venture capital funds agnostic to sector and geography. We invest and partner with teams who use technology to build valuable and lasting businesses, often in industries long overdue for change.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series C, Series B, Series D
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 67
- Round size: Series B $10M–$150M; Series C $15M–$142M; Series D $15M–$300M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — raised $850M in 2017
Portfolio highlights
- Neocis — Yomi, a dental robot, is the next generation in implant surgery that can give patients a better experience, expand your offerings and boost your efficiency
- GreyOrange — Learn about GreyOrange 2026 from GreyOrange, where AI-driven warehouse and retail store solutions reduce costs, increase accuracy and power omnichannel success.
- Helion Energy — Enabling a future with unlimited clean energy
Smith & Nephew PLC designs, manufactures and markets orthopedic devices, sports medicine and ENT technologies, and wound-care solutions. Slightly more than 40% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is a sports medicine and ENT. The remaining 27% of revenue is from the advanced wound therapysegment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Show more...Investment focus
- Industry: Medical Device, Medical, Health Care
- Stage:Series B, Series C
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- OrthoSpace — OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures.The company’s first product has the CE mark and iscurrently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion.
- Trice Medical — Perform a full diagnostic arthroscopy on an HD tablet thanks to the mi-eye 2. Get mi-eye 2 for your doctor's office today.
- Michelson Diagnostics — Michelson Diagnostics is the developer and manufacturer of products based on Multi-Beam Optical Coherence Tomography (OCT), the uniquely powerful, innovative optical imaging technology that is capable of imaging living tissue microstructure at < 10 µm resolution,in real time, to depths of 1 mm or more.
Firstime Ventures is investing in companies who are building a sustainable & accessible future for all.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Seed, Series B
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 81
- Round size: Seed $600k–$6M; Series A $500k–$10M; Series B $12M–$21M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — raised $50M in 2017
Portfolio highlights
- Baibys — Baibys is a medical automated platform that provides AI and robotics-based autonomous sperm selection solutions for IVF.
- Securithings — Bringing IT Standards to the IoT Space.
- STAX Engineering, Inc. — The STAX mission is to help 1 billion people significantly through new technologies that promote health, sustainability, reduced environmental toxins, and reduced global warming.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Grove Ventures is a leading early-stage venture capital fund in Israel. It partners early with exceptional Israeli founders who believe th...
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 68
- Round size: Seed $3.5M–$20M; Series A $8M–$50M; Series B $20M–$74M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $185M in 2022
Portfolio highlights
- Niv-AI — Niv-AI develops an AI platform that optimizes power usage in AI data centers by capturing real-time electricity consumption data and dynamically balancing workloads. It addresses bottlenecks where synchronized GPUs create sharp power spikes, unlocking up to 30% of stranded capacity without new hardware.
- NoTraffic — NoTraffic has developed the first AI-powered traffic signal platform that connects road...
- Scala Biodesign — At Scala Biodesign, we provide our partners a unique one-shot computational protein design solutions to dramatically increase the value and accelerate the development of proteins into commercial products.
Group 11 invests in visionary entrepreneurs who are utilizing the unstoppable momentum of AI and FinTech to redraw the landscape of their respective industries. With a goal of creating change across generations and building long term value through technology, Group 11 has emerged as a coveted partner to veteran entrepreneurs at the forefront oftheir fields. Since its inception in 2012, the firm has deployed over $600 million across six funds in some of the world’s most prominent and disruptive technology companies, including: Tipalti, Navan, Next Insurance, HomeLight, Sunbit, Masterschool, Healthee, Dream, and BridgeWise.
Show more...Investment focus
- Industry: FinTech, Software, Financial Services
- Stage:Series A, Series B, Seed
- Geography: United States, Israel
Investor stats
- Total investments: 76
- Round size: Seed $1.5M–$22M; Series A $6M–$34M; Series B $11M–$100M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- venn — Venn creates a new way of urban neighboring by managing homes, creating shared spaces, supporting hyperlocal business initiatives and services, programs events, and facilitating community engagement – all on a neighborhood-wide level. Operating by the motto, “If they build it, they will stay,” venn’s platform encourages urbanites to become activecreators and participants in the development of their community and enables developing neighborhoods to become as vibrant and desirable as the downtown core. Founded in 2016 by people raised in the Big City and in cooperative communities, venn is a new movement of neighboring that impacts tens of thousands of people in three cities (Tel Aviv, Brooklyn, and Berlin) with +75 employees
- Healthee — Insurights is an AI-powered digital platform that allows employees to utilize their health benefits and coverage. It provides employees on-the-spot answers to their health coverage and benefits questions, helps them find lower-cost providers, and lets them know about relevant preventive care benefits to ensure they are healthier.
- Dream Security — Dream Security provides critical infrastructure defensive cyber solutions.
As a young and dynamic company with a spirit of entrepreneurship, we look first and foremost at the vision leading the entrepreneur. We believe that we should be investing in people, before everything else. We want to be investing in companies led by entrepreneurs who are capable of envisioning and growing great companies with products and/or services meeting real market needs in large and growing markets.
Show more...Investment focus
- Industry: Artificial Intelligence, Health Care, Software
- Stage:Series B, Series A, Seed
- Geography: Israel, United States, Switzerland
Investor stats
- Total investments: 21
- Lead/follow: no public data
Portfolio highlights
- Lynxight — Lynxight creates computer vision applications for underwater operations. The company offers a platform with a set of applications utilized across multiple industries: pools, aquaculture, energy, maritime security and infrastructure, among others. Powered by proprietary AI technology, Lynxight enables superior capabilities to manage safety risksand improve operational performance: object detection, measurement and recognition, behavioral analysis, action classification, trajectory optimization and anomaly modeling to predict and forewarn of unplanned situations.Lynxight is hardware agnostic and can be applied in any environment using imaging from above/below water.
- Treetoscope — The first and only commercial device that senses the internal water flow of a plant and directly measures its water consumption and real-time irrigation needs. without extrapolations based on indirect sensing technologies.Treetoscope offers a SaaS irrigation management platform, based on direct plant sensing technology. We tackle one of the mostcrucial challenges farmers face today: water scarcity and irrigation optimization. Our groundbreaking ag-tech enables the unprecedented measurement of real-time actual water use of trees (based on our patented single probe Sap Flow sensor). Through the Treetoscope solution, growers gain great value as a result of the affordability, scalability, and ease of deployment of our technology.
- Intelligent Traffic Control — Intelligent Traffic Control is an adaptive AI-based traffic light real-time management system. It uses advance Supervised and Unsupervised Machine Learning algorithms to make a real-time analysis of the intersection situation, recognize the traffic pattern and tendencies, and changing the green light allocation per lane accordingly, assuringminimum waiting time at the intersection by maximizing the intersection capability.ITC mathematically proved that there are many traffic jams that the system can prevent. It accumulates the algorithm based on a complex mathematical equation and set of algorithms.
Shalom Equity Fund
Show more...Investment focus
- Industry: Medical, Sensor, Health Care
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- GeneGrafts — GeneGrafts Ltd. is a biotechnology company developing proprietary technology for modulating excitable tissues, such as of brain or heart, by cell therapy. This new paradigm can be used for treatment of various diseases including Parkinson's disease and other neurological disorders or cardiac arrhythmias.They have developed a noveltechnology platform based on transplantation of cell grafts, isolated from the patient's own body, which defines the ion channels. These grafted cells integrate functionally and structurally with the target organ, and their electrical properties are derived from the expressed ion channels. The electrical properties of target organ are modulated in a predetermined way. This technology is designed for treatment of neurological disorders and cardiac arrhythmias.
- VisionSense — Visionsense develops novel visualization solutions that bring natural stereoscopic sight to minimally invasive surgery (MIS). With advanced sensor technology and proprietary software, the Visionsense system delivers depth perception, 3D-HD resolution images and maneuvering flexibility through the smallest access diameters. Existing MinimallyInvasive Surgery (MIS) vision solutions provide 2D (monocular) images that lack depth perception. This restricts the surgeon’s perspective limiting the ability to perform advanced MIS procedures. With stereovision capabilities, surgeons gain enhanced tissue understanding, improved hand eye coordination and the confidence to use advanced (articulating) surgical tools.
As a top Enterprise software development company, we offer customized and unique business solutions to clients all over the world. Get a free quote today!
Show more...Investment focus
- Industry: Medical, E-Commerce, Health Care
- Stage:Seed, Pre-Seed
- Geography: Qatar
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Fish.qa — www.Fish.qa : Online Fish Market In Qatar to Buy & Sell Fresh Fish Online. Visit Us to Buy Sea Fish Online Now. Free Delivery All Over Qatar! Start Shopping Now!
- At-Home-Doc — Once you are registered in our system, you get 24/7 access to the best western-trained doctors. If you are too sick to leave home or just need a piece of advice, a doctor's visit or medication delivery, you can count on us.
Yozma earned worldwide recognition as the founder of Israel's VC industry.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Series B, Seed
- Geography: Israel, United States, Australia
Investor stats
- Total investments: 24
- Round size: Seed $4M–$4.5M; Series B $2.5M–$59M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- BiSiChem — Invent targeted small molecule drugs that are either first-in-class or second-generation
- Illumigyn — Technology that we developed, creating high-resolution digital images with superior magnification that can substantially improve diagnostic accuracy.
- Meat.The End — MTE revolutionizes food production to create desired textures and provides a solution for food companies, by developing novel ingredients and technological solutions that enhance the texture properties of alternative protein products.
Elron Ventures is an early-stage investor committed to turning promising ideas into global industry leaders, with a proven track record of investments and successful M&As worldwide. Elron invests in cyber security and B2B software. Since its establishment in 1962, Elron stands on the forefront of Israeli innovation both as a founder and earlyinvestor in companies across various industries such as Elbit, Medingo, Given Imaging, Cloudyn, Cyber Secdo, and Alcide.
Show more...Investment focus
- Industry: Information Technology, Software, Health Care
- Stage:Seed, Series A
- Geography: Israel, United States, China
Investor stats
- Total investments: 62
- Lead/follow: no public data
Portfolio highlights
- Cybersixgill — Cybersixgill is the leader in cyber threat intelligence enablement and enrichment. Their fully automated threat intelligence solutions help organizations fight cyber crime, detect phishing, data leaks, fraud and vulnerabilities as well as amplify incident response – in real-time. The Cybersixgill Investigative Portal empowers security teams withcontextual and actionable insights as well as the ability to conduct real-time investigations. Rich data feeds such as Darkfeed™ and DVE Score™ harness Cybersixgill’s unmatched intelligence collection capabilities and deliver real-time intel into organizations' existing security systems. Most recently, Cybersixgill introduced agility to threat intel with their CI/CP methodology (Continuous Investigation/Continuous Protection). Current customers include enterprises, financial services, MSSPs, governments and law enforcement entities.
- CartiHeal — Target improved outcomes in the treatment of knee cartilage and osteochondral defects with a porous, biocompatible and biodegradable off-the-shelf implant.
- Brainsgate — Established in 2000, BrainsGate is a medical device company committed to developing innovative therapies for patients suffering from Central Nervous System (CNS) diseases.BrainsGate's platform...
Mindset Ventures is an early-stage VC firm that supports entrepreneurs in their growth and international expansion. The firm targets B2B startups technology applied to Agriculture, Financial Services, Healthcare, Cybersecurity, Education, and Enterprise Software industry. It was founded in 2016 and headquartered in Sao Paulo, Brazil.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Series A, Seed, Series B
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 82
- Lead/follow: no public data
Portfolio highlights
- deepc — The Radiology AI Platform - Your effortless access to AI
- Tamnoon — Tamnoon develops a state-of-the-art cloud security platform to empower security teams and manage cloud risks effectively. By harnessing the power of AI combined with human expertise, the company empowers security teams and equips organizations of all sizes with exceptional cloud protection capabilities.
- Backed Finance — Backed is a bridge between stocks, ETFs and the emerging DeFi ecosystem.
S2G Ventures is is a multi-stage venture fund investing in food and agriculture. We're harnessing the power of food innovation to create better outcomes for people and the planet.
Show more...Investment focus
- Industry: Food and Beverage, Agriculture, Biotechnology
- Stage:Series A, Series B
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 159
- Lead/follow: no public data
Portfolio highlights
- Catalera — Catalera BioSolutions offers proprietary bio-based pest control products to enhance the well-being of people, plants, and planet.
- Exacto — Exacto is an innovative turnkey adjuvant manufacturer for agricultural, T&O and industrial vegetation management markets.
- Amperage — Amperage provides a full-service platform that focuses on directly investing and growing broadband infrastructure.
Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Sweden, Israel, Iceland
Investor stats
- Total investments: 13
- Lead/follow: no public data
Portfolio highlights
- AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
- XNK Therapeutics — XNK Therapeutics, founded in 2012, is one of the pioneering companies within the landscape of cell therapy.
- Vitara Biomedical — Vitara Biomedical has developed a therapeutic platform to support premature infants. Vitara Biomedical's platform was inspired by natural physiological processes to transform neonatal care.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Technion Seed is a seed-stage investment firm, owned jointly by four top-tier Venture Capital funds – Vertex Venture Capital, Battery Ventures (US-based), SCP-Vitalife and ProSeed – and the Technion Research & Development Foundation. Through Technion Seed, these funds invest in high market potential technological ideas and ventures, thatare still at an early stage and with very high uncertainty. The investment in such ventures – initially up to about $1,000,000 – is made both directly by the funds and indirectly through Technion Seed. The purpose of the initial investment is to enable the entrepreneurs to prove the viability of their idea. Success in the initial phase will then lead to a large round of financing by the funds, for continued growth of the venture. Technion Seed and its owners invest in a wide variety of areas, including communications, IT, internet, medical devices, renewable energy, new materials and more.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Seed
- Geography: Israel, United States
Investor stats
- Total investments: 8
- Lead/follow: no public data
Portfolio highlights
- Aren — Aren is an AI-powered platform that empowers engineers and asset owners to assess and manage civil infrastructure while minimizing the risk of failure and optimizing budgets. Its technology offers a cost-effective, automated, and quantitative approach to de-risk the asset management practice using computer vision and machine learning.
- VineSight — Protect your Brand, Cause, Campaign, Organization. Spot and eliminate attacks before they go viral.
- Envizion Medical — ENvizion Medical is now ENvue Medical. Enhanced Navigation. Expanded Vision. Same technology Same team New company ENvizion Medical is now ENvue Medical. Enhanced Navigation. Expanded Vision.
TechWald Holding S.P.A. - TWH - Operational Holding Company supporting high growth potential early stage companies committed to develop Healthcare Innovation.We have a key strategy focus on MedTech industry and Medical Technologies - medical devices, equipment, digital devices and services -which can provide benefit and value for Patients, Doctors and Healthcare Systems,and reward Shareholders with a sound and ethical profit
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series B, Series C
- Geography: Israel, United States
Investor stats
- Total investments: 9
- Round size: Series A $3.6M–$7.1M; Series B $8.5M–$20M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- NitiNotes — Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight.
- SentiAR — SentiAR is digital health, software device company adding a new dimension to clinical practice in interventional procedures. Spun out of Washington University, we are developing the first 3D visualization platform using real-time holography of the patient's anatomy and catheter location, "floating" over the patients, with a goal toprovide the clinician and patient a faster, safer delivery of care.SentiAR’s mission is to transform the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient.The visualization is fully controllable “hands-free” by the clinician, providing an ergonomic breakthrough for the treatment and analysis of cardiac arrhythmias within an interventional catheter lab environment. SentiAR is developing the platform for eventual FDA submission.
- Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.
The Scientific and Technological Research Council of Turkey (TÜBİTAK) is the leading agency for management, funding and conduct of research in Turkey. It was established in 1963 with a mission to advance science and technology, conduct research and support Turkish researchers. The Council is an autonomous institution and is governed by a ScientificBoard whose members are selected from prominent scholars from universities, industry and research institutions. TÜBİTAK is responsible for promoting, developing, organizing, conducting and coordinating research and development in line with national targets and priorities. TÜBİTAK acts as an advisory agency to the Turkish Government on science and research issues, and is the secretariat of the Supreme Council for Science and Technology (SCST), the highest S&T policy making body in Turkey.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Grant, Pre-Seed, Seed
- Geography: Turkey, United Kingdom, United States
Investor stats
- Total investments: 31
- Round size: Seed $50k–$2.5M; Grant $3k–$230k; Pre-Seed $20k–$521k
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Navirid — Navirid is a technology company specializing in IoT and embedded systems, dedicated to developing advanced radar technologies and safety solutions to connect motorcyclists to life and enhance their riding experience.The radar-based systems we develop provide riders with real-time environmental awareness, establishing a new safety standard inmotorcycle use with critical features like blind spot detection, collision warning, and multi-target tracking.Our vision is to make motorcycles an integral part of the intelligent transportation ecosystem; our mission is to connect riders more firmly to life on every journey.
- VulnHero — VulnHero is an AI-powered offensive security platform that delivers continuous full-stack security testing, exploit-aware vulnerability intelligence, and contextual attack surface management in a single solution.By combining live CVE & exploit telemetry, technology stack discovery, exploitability-first risk scoring, and automated validationworkflows, VulnHero helps organisations identify and prioritise what’s actually exploitable across their entire digital landscape.Built for CISOs, AppSec teams, and red teams, the platform integrates with existing SIEM, SOAR, ticketing, and DevSecOps pipelines, providing actionable, evidence-based insights instead of scanner noise.
- Viseur AI — Viseur AI delivers a cutting-edge medical imaging solution powered by artificial intelligence. Our platform provides robust, scalable, cost-effective long-term radiology and digital pathology solutions through end-to-end automation.
XTX Ventures is the venture capital arm of XTX Markets. XTX Markets is a leading, innovation-driven algorithmic trading firm.XTX Ventures focuses on early stage startups (Seed to Series A) applying machine learning and leverages XTX Markets’ deep expertise in ML and financial technology to help grow and enhance those businesses. We are geographyand industry agnostic.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Series A, Seed
- Geography: United Kingdom, United States, Israel
Investor stats
- Total investments: 65
- Lead/follow: no public data
Portfolio highlights
- iGent — iGent AI focus on integrating advanced AI capabilities into the software development process.
- Verax AI — Seeks to be the leading provider of enterprise-grade trust solutions for Generative AI, enabling companies worldwide to build or adopt any Generative AI agent with confidence
- Oriole Networks — At Oriole Networks, we are pioneering the use of optical switching to create the fastest and most energy-efficient network. This innovative approach is accelerating the next generation of machine learning in high-performance computers and data centres, promising exciting possibilities for the future.
We are a VC firm investing in pre-seed and seed stage startups. We back exceptional Founders building market-transforming companies.
Show more...Investment focus
- Industry: Software, Information Technology, Marketplace
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 271
- Lead/follow: no public data
Portfolio highlights
- Mana.bio — Mana.bio is an AI based drug delivery startup, focusing on gene therapy including RNA and DNA-based therapeutics and vaccines
- Gizmo — AI quizzes that help you learn and remember anything
- Stoke Space — STOKE Space Technologies seamlessly connecting earth and space.
Binder & Partners Ventures is the investments' capital arm of Binder & Partners multi-family office. The ambition of BPV is to connect our investors with the most promising startup companies.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, France, United States
Investor stats
- Total investments: 14
- Lead/follow: no public data
Portfolio highlights
- Rookout — Code doesn’t always behave as you expect it to and your team is wasting too much time to understand why. Rookout provides secure, fast, and simple data access, no matter what architecture or where the code is running. By providing the developer with instant, laser-focused data, developer teams can understand their code and see an increase inproductivity, velocity, and efficiency.
- Lumen — Lumen is a device and app that measures your metabolism in a single breath and provides daily personalized nutrition based on your metabolic data. Through the device and app, you can achieve your fitness goals whether they be weight loss, performance optimization, or simply improving your metabolic health.As a company, we are a team ofscientists, researchers, engineers, and designers, aimed at improving the way people understand their metabolism. We believe that a healthy metabolism is a key to better health and that everyone can attain it with a little help from Lumen.At Lumen, we are all about teamwork, friendship, and family. Curious about joining? We are always looking for creative people who share our passion for health and fitness to join our team.
- Blink Technologies — Blink Technologies is developing a robust, non-intrusive passive, eye-tracking technology without the need for special dedicated hardware. Their non-invasive, AI-based Software Solution can be deployed with any Camera technology on the market today. The proprietary solution integrates with any OS and can run locally (edge-based) or remotely(cloud-based).Blink Technologies was founded in 2018 and is based in Palo Alto, California, United States.
Impact investing in Israeli technology. ZORA is an impact investing fund investing in early-stage Israeli companies solving global challenges in health, education, economic inclusion and the environment.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Internet
- Stage:Seed, Series A, Convertible Note
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 13
- Round size: Seed $1M–$7M; Series A $4M–$6M
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- BiotaX — Microbiome Genomic Analysis Cloud Platform | Biotax.co
- Newmoo — Newmoo makes plant-based cheeses and dairy alternatives.
- Forsea Foods — Forsea Foods develops cell-cultured seafood through the use of patented organoid technology which allows them to bypass the scaffolding stage of cultivated meat production.
Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI).
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 14
- Round size: Series A $4M–$55M; Series B $15M–$33M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
- Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
- Elicio Therapeutics — Elicio ground-breaking Amphiphile technology is engineering potent vaccines and immunotherapies to defeat an array of aggressive cancers.
Good Company Fund is investing in early-stage companies that leverage deep technologies to solve the world’s biggest problems. The firm is constantly seeking bold entrepreneurs who are building frontier technology solutions. Good Company Fund is generally looking to invest in innovative, hyper scalable, software solutions. It is especially excitedabout: Future of Energy, Future of Work and Education, Future of Work, Circular Economy, Precision Farming, and Digital Health. However, it is constantly learning and looking for additional opportunities in other verticals and aiming to invest in the "Operating System of the New, Sustainable World".Good Company's studio brings together multinational corporations, entrepreneurs and capital, in order to solve the world’s biggest problems. Good Company Studio is a home for entrepreneurs who want to create businesses with a purpose. The Studio is a pre-seed platform that provides entrepreneurs with capital, network, go-to-market, mentoring, and support.
Show more...Investment focus
- Industry: Social Impact, Software, Recruiting
- Stage:Pre-Seed, Seed, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 16
- Round size: Seed $2.9M–$22M; Pre-Seed $400k–$2.8M; Series A $5M–$17M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Jotit — Jotit is a cutting-edge educational technology startup that uses handwriting tools to help kids, instructors, and parents stay organized.
- TULU — TULU is a smart platform and amenity services provider to over 10,000 people in 50 buildings across the United States, Europe and Israel. Founded in 2019, TULU provides urban tenants with on-demand access to hundreds of brand name appliances, grocery staples, micro-mobility and entertainment devices, and more. TULU’s IoT-based modular units arecustomized to provide the most necessary and useful items, while leveraging advanced machine learning tools to analyze behavioral patterns, optimize usage, refine inventory, and create a personalized experience for our users. The outcome is a new way of living, encouraging more responsible consumption, reducing the cost of living in the city, and consistent with the trend to smaller and smaller living spaces.
- Algocell — Optimize precision fermentation and cell culture bioprocesses using Digital Twin, AI and Hybrid Models. Create your first model now!
Robin Hood Ventures investments for startups range from $250,000 to $1 million. We syndicate with venture capitalists, institutions, and other network angels.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United States, Israel
Investor stats
- Total investments: 130
- Round size: Seed $210k–$3M; Series A $100k–$11M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Epoxy.ai — We make sports viewing and gaming easy and fun for everyone
- Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
- Lia — LIA Diagnostics is redesigning pregnancy tests to addresses the challenges surrounding privacy, usability and sustainability in current pregnancy tests.
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical VC Funds in Middle East investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 VC funds investing in Middle East Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!